Skip to main content

Our genetic engineering biotech closed a fundraising of 1M€ from private investors. GEG-Tech is a highly disruptive firm in the field of genetic engineering and develops a technological platform with a wide range of applications for the life science industry, notably immunotherapy cancer, gene therapy and other high potential areas.

The new funding will enable to further invest into technology applications and to enable partnerships with industrial groups.